Cronos Group Inc. Common Share (CRON) is a publicly traded Healthcare sector company. As of July 26, 2026, CRON trades at $2.82 with a market cap of $1.05B and a P/E ratio of 281.60. CRON moved +2.37% today. Year to date, CRON is +6.84%; over the trailing twelve months it is +35.75%. Its 52-week range spans $1.60 to $3.43. Analyst consensus is buy with an average price target of $3.32. Rallies surfaces CRON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Cronos Group Inc. Common Share (CRON) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CRON moved +2.37% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $2.82 |
| Market Cap | $1.05B |
| P/E Ratio | 281.60 |
| EPS | $0.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.43 |
| 52-Week Low | $1.60 |
| Volume | 1.19M |
| Avg Volume | 0 |
| Revenue (TTM) | $159.53M |
| Net Income | $5.06M |
| Gross Margin | 42.73% |
3 analysts cover CRON: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.32.